Sarepta Therapeutics (SRPT) PT Raised to $192 at Baird
Tweet Send to a Friend
Baird analyst Brian Skorney raised the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $192.00 (from $181.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
